Wenfeng Fang

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 15 篇 · 总被引 373 次 · h-index 7

代表论文

• High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer (2015 · Oncotarget · 被引 198)
• Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC (2025 · New England Journal of Medicine · 被引 60)
• DNASE1L3-expressing dendritic cells promote CD8+ T cell function and anti-PD-(L)1 therapy efficacy by degrading neutrophil extracellular traps (2025 · Cancer Cell · 被引 28)
• Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies (2016 · The Oncologist · 被引 28)
• Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma (2015 · 癌症：英文版 · 被引 14)
• QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC (2015 · Scientific Reports · 被引 8)